![International Top Stories from Associated Press (AP) show](/assets/missing_small.png)
Summary: WASHINGTON , Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply. The giant health insurance program for seniors long ago flagged compounded drugs produced for the mass market without oversight from the Food and Drug Administration as safety risks.